< PreviousCONTRACEPTION20Pharma Business International www.pbiforum.net /9:74825.,08754:5+:6:5409.671(:'728/0548251:*711:&63:6:&68923/9.:-5-948:+52&5-943:17'9268754:64.:39!,61:+299.5-#,8:8/9:-619:9,7$61948:29-6743:91,37$9&78/:-538:9++5283:3861174)#: /73:05-93.5&4:85:-94:-986'517374):64.:0196274)5,8:8/9:/52-5493:6:*711:.917$923:855,70"1(:+52:78:85:'9:05437.929.:9++9087$9#:96173870611(%:8/73:196$93:-94:&78/:$92(+9&:5*87543:&78/:054.5-3:29-67474)8/9:-538:05--54:64.%:02,07611(%29176'19:05482609*8754:0,229481(6$6716'19#:62:+25-:.9892274)2939620/923%:8/73:38689:5+:6++6723:/633*,229.:3079487383:54%:64.:45&:6:896-5+:74$9387)68523:+25-:8/9:47$92378(:5+63/74)854:9.7061: 94829:/6$9.9$915*9.:6:-619:05482609*87$9:*711# /9:*711%:8/9(:36(%:73:9++9087$9%:36+9:64./63:45:.9827-94861:7-*608:54:39!:.27$9#: /9:9!*927-94861:49&:.2,)%:06119..7-98/64.251549:,4.90645689:52 %:7401,.93:6:154)0/674:+688(:607.&/70/%:8/9:896-:9!*16743%:315&3:.5&48/9:019626409%:-96474):541(:549:.53973:499.9.:74:6:8&948(+5,2:&74.5&#: /9:2939620/923:3,00933+,11(:89389.:685861:5+:8/299:.5393:5+:8/9:.2,)::%:64.:-):293*9087$91(::54:549/,4.29.:/9618/(:-94:6)9.:'98&99497)/8994:64.:+7+8(:(9623:51.#:+:8/939%97)/8(8/299:05-*1989.:8/9:38,.(#,'9083:86"74):8/9:-):.536)9:5+:9!/7'789.:6:-62"9.:3,**293375474:19$913:5+:893853892549:64.:8&5/52-5493:29,729.:+52:3*92-*25.,08754#: /9:'7))938:.26&'60"%/5&9$92%:73:8/68:8/9:*711:541(:&52"9.:7+:78&63:86"94:&78/:+55.#:++9087$94933.9*94.948:54:'974):86"94:&78/:+55.05,1.:'9:6:-652:733,9:+52:6./929409#9-619:'728/:0548251:*7113%:54:8/9:58/92Finding apill for men079487383:29-674:054+7.948:8/68:6:36+9%:9++9087$9:64.:29$9237'19:-61905482609*87$9:&711:9$948,611(:'905-9:296178(%:8/5,)/:68:*293948%5*87543:+52:-94:29-674:8/74:54:8/9:)25,4.#:528,46891(%:2939620/:73(791.74):35-9:*25-7374):49&:.9$915*-9483#:20-23_Layout 1 11/04/2018 10:50 Page 1Pharma Business International 21www.pbiforum.netCONTRACEPTION© Shutterstock / Aleksandra Berzhets 22 Á/64.%:629:36+9:64.:9++9087$9:85:86"9:5464:9-*8(:385-60/#:93*789:8/73:.26&'60"%:8/929:73:-,0/85:'9:9!0789.:6'5,8%:93*907611(:+52:-948/9-391$93#: /9:*711:6005,489.:+52:15&19$913:5+:0720,16874):893853892549:',8%63:8/9:2939620/923:&929:"994:85:*57485,8%:541(:6:/64.+,1:5+:8/9:3,'90839!/7'789.:3(-*85-3:5+:893853892549.9+707940(:52:9!0933:8/5,)/:6113,'9083:.7.:9!*9279409:35-9:&97)/8)674 #: (*70611(%:893853892549:.9+707940(-647+9383:63:6:.9029639.:39!:.27$9%92908719:.(3+,408754%:8729.4933%.9*2933754%:&97)/8:)674%:64.:-9-52(1533%:6-54)38:58/923#:'$75,31(%:605482609*8754:&/70/:06,393:8/939733,93:&78/:64(:+29,940(:&5,1.37-*1(:+15,4.92#::0639:74:*5748:29)62.3:6:01747061:89389!*15274):8/9:9++7060(:5+:64:749086'19-619:05482609*8754:'60":74:#93*789:*53874):6::*92:0948:3,009332689%:8/9:82761:&63:0,8:3/528:6+892:37.99++9083:3,0/:63:-55.:3&74)3:64.:6049-647+9389.:74:*628707*6483#:+:05,239%8/73:392$9.:85:/7)/17)/8:-64(:37-71623,0/:37.9:9++9083:*293948:74:&5-943'728/:0548251#:64(:&5-94:/6$99!*9279409.:&97)/8:)674:52.9*2933754%:64!798(:64.:&5239'906,39:5+:8/972:'728/:0548251:*711#458/92:*25-7374):38,.(:7485:620-23_Layout 1 11/04/2018 10:50 Page 2CONTRACEPTION22Pharma Business International www.pbiforum.net*58948761:-619:'728/:0548251:*711:/638,249.:85&62.3:468,29:+52:783:743*7268754#9*52874):74:8/9:;5,2461:5+:9.707461 /9-7382(%:2939620/923:+25-:8/9-927064: /9-7061:50798(:/6$9.986719.:6:268:38,.(:.9-543826874):6)55.:196.:+52:6:-619:'728/:0548251:*711# /73:*589487611(:)6-90/64)74)'296"8/25,)/:73:'639.:54:5,6'674::6/9628385**74):*57354:8/68:+27064&6227523:64.:/,48923:,39.:54:8/9726225&3#: /73:*1648:9!82608:73:+5,4.:748&5:8(*93:5+:+27064:*16483:63:&911:63'974):468,2611(:*25.,09.:74:8/9:'5.7935+:-6--613%:&/929:78:73:8/5,)/8:850548251:'155.:*2933,29#:4.99.%:.50852335-987-93:*293027'9:3-611:.5393:5+:8/905-*5,4.:85:/9628:68860":*6879483#,6'674:.732,*83:8/9:*6336)9:5+35.7,-:64.:06107,-:7543:8/25,)/:8/9-9-'2649:*258974:6% 6393%&/70/:629:+5,4.:74:0911:-9-'26493:64.629:-6.9:,*:5+:*258974:3,',4783#:5-93,',4783:629:+5,4.:74:062.760:8733,9%:',8549:8(*9:5+:3,',478::06119.:6::73:+5,4.541(:74:3*92-:09113#: /73:*258974:73:"45&485:'9:02787061:74:+9287178(%:68:19638:74:-619-709#:2752:01747061:38,.793:/6$9:3/5&48/68:5,6'674:0,2'3:+9287178(:74:-94#5&9$92%:5,6'674:78391+:7348:64:5*8754:636:05482609*87$9:'906,39:5+:8/9:273":5+/9628:.6-6)9#:(:29-5$74):6:3,)62:)25,*:+25-5,6'674:64.:6135:29*16074):783:1608549)25,*:&78/:6:8276519:)25,*%:8/92939620/923:029689.:6:.927$687$9:8/68:73*62870,1621(:)55.:68:92574):74:54:6:743*92-:09113:74:2683#:409:'5,4.%:7874892+9293:&78/:8/9:09113:6'7178(:85:3&7-%&/70/:73:933948761:85:783:2519:74:+92871774)64:9))#: /9:2939620/923:36(:8/68:8/905482609*87$9:9++908:3/5,1.:'9:29$9237'19'906,39:6:73:541(:+5,4.:54:-68,293*92-:09113#: /68:-9643:3*92-:09113*25.,09.:6+892:385**74):82968-948:&78/8/9:5,6'674:.927$687$9:3/5,1.48:'96++9089. /9:15,.938:06113:+52:6:-619:549.671('728/:0548251:*711:629:-94:8/9-391$93#64(:&5,1.:*29+92:8/73:5*8754:85054.5-3:52:74:*1609:5+:6:*5894876174908754:52:)91#:.$506893:6**2907689/6$74):)296892:0548251%:64.:458:291(74)54:6:374)19:05482609*8754:61549#:8/923367.:78:&5,1.:029689:6:-529:25',38*258908754:&/94:,39.:74:864.9-:&78/:6054.5-#:64(:-94:&5,1.:*29+92:8/735*8754:85:6:$639085-(%:)7$94:783:689-*5262(:64.:96371(:6./929.:85:05,2395+:608754#:4.:58/92:-94:17"9.:8/9:7.965+:86"74):0/62)9:5+:8/972:5&4293*5437'7178(#:,8:-538:6)299:8/68:8/9*58948761:37.9:9++9083:&5,1.:.9+747891(+60852:7485:8/972:.9073754#:83:155"74):740296374)1(:17"91(:8/68:605--9207611(:6$6716'19%:29$9237'19:64.5409.671(:-619:05482609*87$9:&711:'9:6296178(:74:8/9:49!8:+9&:(9623#:4:8/9748927-%:8/929:629:38711:733,93:85:&52":5,864.:-529:2939620/:85:'9:.549#:,805482609*8754:73:0/64)74)%:8/68:-,0/:73.9+74789#:© Shutterstock / StockPhotosArt 20-23_Layout 1 11/04/2018 10:50 Page 3© Shutterstock / ArtOfPhotos 20-23_Layout 1 11/04/2018 10:50 Page 4COMPLIANCE24Pharma Business International www.pbiforum.net#5>?15<70<4>2=:4<6?;>4=87?:;?89>8/?=5>?08;=?=:-5=6.?7>-26<=>3?8/?<66? 29;2717:;:9-?+5>9?178324=?;</>=.?5<;=8?,>?<,;862=>6.?:9=>9;>?=8?>9;27>178324=;?7><45?489;20>7;?<=?=5>5:-5>;=?"2<6:=.?<93?<*8:3?18=>9=:<6/6<;518:9=;)?<11:6.(?0<92/<4=27>7;<93?3:;=7:,2=87;?<7>?0>>=:9-?=5>;>7>"2:7>0>9=;?>9;27:9-?178324=;?<7>178324>3?:9?<?46><9?<93?;>427>>9*:7890>9=)'5<70<4>2=:4<6?4801<9:>;?<7>>1>4=>3?=8?48016.?+:=5?=5>?*<7:82;47:=>7:<?:9=78324>3?,.?87-<9:;<=:89;;245?<;?=5>?!?<93?=5>?)?9>+<.?:9?+5:45?=5>.?4<9?38?=5:;?:;?,.0<&:9-?2;>?8/?5:-5?"2<6:=.?:9;1>4=:89<93?3>=>4=:89?;.;=>0;)?5:>/?<089-=5>?7>"2:7>0>9=;?/780?0<9.?,83:>;:;?=5<=?=5>?46:9:4<6?=7:<6;?;=<->;?8/?<372-;?3>*>6810>9=?<7>?<35>7>3?=8<;?;=7:9->9=6.?<;?18;;:,6>)6:9:4<6?=7:<6;?8/=>9?0<&>?87?,7><&?<9>+?178324=(?+:=5?0245?8/?=5>?/2=27>;244>;;?8/?52->?:9*>;=0>9=;?,>:9-3>=>70:9>3?89?58+?=5>?178324=:9=>7<4=;?+:=5?520<9;)?5:6>?=5>7>?:;<6+<.;?*<;=?<0829=;?8/?=>;=;?=5<=;58263? ?<93?+:66? ?5<*>?,>>9293>7=<&>9?89?=5>?178324=(?=5>7>?:;<6+<.;?=5>?3:;<;=782;?18;;:,:6:=.?=5<==5>7>?+:66?,>?<9?<3*>7;>?7><4=:89+5>9?:=?:;?:9=78324>3?=8?*8629=>>7;?:9=5>?46:9:4<6?=7:<6;)6:9:4<6?=7:<6;?896.?480>?:9=8?16<.894>?=5>?17>46:9:4<6?<93?=>;=:9-1784>327>;?5<*>?,>>9?48016>=>3(<93?:9?08;=?4<;>;?4<9?896.?,>293>7=<&>9?</=>7?7>4>:*:9-?<1178*<6,.?<9?<2=587:;>3?,83.?;245?<;?=5>!)?:-27>;?;2-->;=?=5<=?:=?4<9?=<&>21?=8?=>9?.><7;?89?<*>7<->(?<93?48;=<9?:947>3:,6>?) ?,:66:89?/87?<?372-?=80<&>?:=?=5782-5?<66?=5>?;=<->;?8/46:9:4<6?=7:<6;)?93?6>;;?=5<9??1>74>9=?8/?9>+?0>3:4:9>;?>*>9?0<&>?:=1<;=?!?;47>>9:9-(?<93?:9=8?15<;>?8/?46:9:4<6?=7:<6;)?93?:=?:;?<?026=:15<;>?1784>;;(?8/?4827;>)?9?08;=4<;>;?:=?+:66?/:7;=?,>?=>;=>3?89?<?;0<66920,>7?8/?*8629=>>7;(?+:=5?=5>7>;26=;?8/?;245?,>:9-?089:=87>3,>/87>?:=?:;?=5>9?=>;=>3?89?52937>3; ?<93?>*>9=2<66.?=582;<93;?8/*8629=>>7;)8016:<94>?+:=5?=5>;>7>"2:7>0>9=;?:;?<?3://:426=?52736>(?,2=89>?<66?4801<9:>;?<7>?/<4>3?+:=5?<93New products must meet regulations and standards, whichcan prove the biggest hurdle for many new drugs looking toenter the market26 ÁEnsuringcompliance24-27_Layout 1 11/04/2018 10:51 Page 1Pharma Business International 25www.pbiforum.netCOMPLIANCE© Shutterstock / gopixa24-27_Layout 1 11/04/2018 10:51 Page 2COMPLIANCE26Pharma Business International www.pbiforum.net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© Shutterstock / Gorodenkoff24-27_Layout 1 11/04/2018 10:51 Page 3Pharma Business International 27www.pbiforum.netCOMPLIANCE-2:3>6:9>;?=8?:93:4<=>?<93?;>=?21>1>4=<=:89;?/87?=5>?7>4873:9-(38420>9=:9-?<93?<745:*:9-?1784>;;)?8668+:9-?</=>7?=5<=?:;?2<6:=.;;27<94>?178-7<00>;(?:94623:9-?=5>7>;189;:,:6:=:>;?8/??'>7;899>6?+:=5:9=5>?6<,)?<4:6:=:>;?:9?->9>7<6(?+5:45:9*86*>;?98=?2;=?=>;=?;.;=>0?/<4:6:=:>;?,2=<6;8?/<4:6:=:>;?/87?5<936:9-?=>;=;?<93<745:*:9-)?<;=>?3:;18;<6?:;?<6;848*>7>3(?1<7=:426<76.?+:=5?=5>?5<<7382;;?<93?3<9->782;?9<=27>?8/?0<9.?,.178324=;?47><=>3?:9?=5>?6<,)?5>9?:=?480>;?=8?;=23.?16<9;?<937>187=;(?=5>?$%'?6<.;?82=?7>"2:7>3489=>9=?/87?=5>?;=23.?16<9?:9?=>70;?8/<:0;?<93?-8<6;(?3>=<:6;?8/?=5>?;189;87<93?<9.?<33:=:89<6?=>;=?/<4:6:=:>;?:9*86*>3:9?=5>?=>;=;(?<93?0245?087>)?#5>?-8<65>7>?:;?=8?>9;27>?=5<=?<9.?<93?<66=7<9;1<7>94.?:;?8,;>7*>3?+5>9?:=?480>;=8?688&:9-?8*>7?87?12,6:;5:9-?=5>?7>;26=;8/?<9.?=>;=;)?4<93<6;?:9?1<;=?.><7;?5<*>;58+9?=5<=?6<,;?;189;87>3?,.?:93:*:32<64801<9:>;?0<.?/:93?7>;26=;?=5<=?,>9>/:==58;>?4801<9:>;?=8?=5>?3>=7:0>9=?8/;4:>9=:/:4?178=8486)?$%'?4<9?5>61?7>324>=5:;(?87?<=?6><;=?12=?;</>-2<73;?:9=8?16<4>=5<=?<668+?:9*>;=:-<=87;?=8?688&?,<4&?8*>7=5>?1784>;;?<93?:3>9=:/.?:/?=5:;?0:-5=?,>=5>?4<;>)$%'?5<;?<6+<.;?,>>9?7>/>7>94>3?<;;80>=5:9-?8/?<?-2:3>6:9>(?,2=?/87?0<9.4829=7:>;?4>7=<:9?<;1>4=;? ?87?=5>?>9=:7>=. ?8/?:=?5<*>?,>>9?12=?:9=8?6<+)?#5>2781><9?9:89?<381=>3?=+8?,<;:4!:7>4=:*>;?<93?<?!>4:;:89?7>6<=:9-?=8?=5><116:4<=:89?8/?=5>?$%'?17:94:16>;?:9?(+5:6>?;80>?45<9->;?+>7>?0<3>?=8?=5:;?:9 (?0245?8/?:=?;=:66?38>;?<116.)?#5>;>:94623>?480126;87.?<23:=;?<93:9;1>4=:89;?=8?>9;27>?=5<=?6<,?/<4:6:=:>;489/870?=8?$%'?726>;?<93?7>-26<=:89;? ;8?:=?:;?*>7.?0245?<9?:;;2>?8/48016:<94>)24-27_Layout 1 11/04/2018 10:51 Page 4MERGERS & ACCUSITIONS28Pharma Business International www.pbiforum.net© Shutterstock / MichaelJayBerlin28-31_Layout 1 11/04/2018 10:52 Page 1Pharma Business International 29www.pbiforum.netMERGERS & ACCUSITIONS);DE3A>=BE3D4E8@?B;=E@3E!%' E1>@75;BE4AB;EABECE3<7>>2E@3E8C@>E9DC<=A?EB;DE6;C>8CE+*E=6C:D.ECEB>D?9EB;CBE;C=E@?<2E:@?BA?7D9EB@E5>@4C=E4DE8@/DEB;>@75;E*6>A<EC?9EA?B@E+C20E)@E1D5A?EB;A=EA==7D,=E>@7?9(76.E4D,<<E3A>=BE3@:7=E@?EB;DE1A<<A@?E9@<<C>E9DC<=EB;CBE;C/DEBC-D?E6<C:D<CBD<2EEC?9EB;D>D,=E1DD?E=D/D>C<0EA>=BE76EA=E+C<<A?:->@9B,=E'0!E1A<<A@?EC:$7A=ABA@?E@3E1A@6;C>8C#7:C86@E;C>8C:D7BA:C<=.E4;A:;E:@86<DBD9EA?EB;DE8A99<DE@3D1>7C>20E);DE9DC<E=C4E#7:C86@E1D:@8DECE4;@<<2E@4?D9=71=A9AC>2E@3E+C<<A?:->@9B0E*=E4D<<EC=E1@<=BD>A?5EAB=E6>@3A<D.EB;DE9DC<C<=@E=C4E+C<<A?:->@9BE1@@=BEAB=E?DC>(BD>8E?DBE=C<D=EC?9EDC>?A?5=0E+C>-E)>79DC7.E+C<<A?:->@9BE&.E=CA9ECBEB;CBEBA8DEB;CBE9DC<E4C=C?EA86@>BC?BE?D"BE=BD6EB@4C>9=E@7>E/A=A@?E@3E1D:@8A?5EC?A??@/CBA@?(9>A/D?E=6D:AC<B2E6;C>8C:D7BA:C<E5>@4B;E:@86C?2E3@:7=D9@?EA86>@/A?5E@7B:@8D=E3@>E6CBAD?B=E4AB;E=D/D>DEC?9E:>ABA:C<:@?9ABA@?=07=BE9C2=EC3BD>.EB;DE6;C>8CE+*E8C>-DBE:<@:-D9E76EC?@B;D>1A<<A@?E9@<<C>E9DC<0E);A=EBA8DE@:;DE=4@@6D9E3@>E*<6;C1DB(1C:-D9:C?:D>EC?C<2BA:=E=BC>B(76E<CBA>@?EDC<B;E3@>E'0E1A<<A@?0E*::@>9A?5EB@E@:;D.EB;DE9DC<E4A<<E:>DCBDEC?EA?97=B>2(4A9D9D/D<@68D?BEC?9E9D<A/D>2E@3E1>DC-B;>@75;E8D9A:A?DE3@>E:C?:D>6CBAD?B=0E);A=.EABED"6<CA?D9.E4A<<E1DEC:;AD/D9E/ACE<CBA>@?EDC<B;,=?DB4@>-E@3E:@887?AB2E@?:@<@52E6>C:BA:D=EC?9EC:C9D8A:E8D9A:C<:D?B>D=EC:>@==EB;DE?ABD9E#BCBD=0E@:;DE&EC?AD<E,C2EC99D9B;CBEB;DE9DC<EA=EC?EA86@>BC?BE=BD6EA?EB;DE:@86C?2,=E@?5@A?56D>=@?C<A=D9E;DC<B;:C>DE=B>CBD520ECB:;EB;A=E=6C:D0E30 ÁAs of writing, around $156 billion worth of deals hasalready taken place in the pharmaceutical M&A market thisyear, spearheaded by major industry players such asSanofi, GSK and Celgene. Here Pharma BusinessInternational explores some of the biggest deals that havetaken place over the last few months. Billion dollardeals28-31_Layout 1 11/04/2018 10:52 Page 2Next >